{"id":"https://openalex.org/W2992862872","doi":"https://doi.org/10.14309/01.ajg.0000613072.37136.77","title":"P026 Investigating Predictors of Antibodies to Infliximab Formation in Inflammatory Bowel Disease \u2013 The Importance of Immunomodulators","display_name":"P026 Investigating Predictors of Antibodies to Infliximab Formation in Inflammatory Bowel Disease \u2013 The Importance of Immunomodulators","publication_year":2019,"publication_date":"2019-12-01","ids":{"openalex":"https://openalex.org/W2992862872","doi":"https://doi.org/10.14309/01.ajg.0000613072.37136.77","mag":"2992862872"},"language":"en","primary_location":{"id":"doi:10.14309/01.ajg.0000613072.37136.77","doi":"https://doi.org/10.14309/01.ajg.0000613072.37136.77","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0000613072.37136.77","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023883177","display_name":"Marcello Raimundo Barbosa de Freitas","orcid":"https://orcid.org/0000-0002-7634-6839","observed_orcids":["https://orcid.org/0000-0002-7634-6839"]},"institutions":[{"id":"https://openalex.org/I4210098124","display_name":"Hospital da Senhora da Oliveira Guimar\u00e3es","ror":"https://ror.org/00y0jw647","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210098124","https://openalex.org/I4405260793"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Marta Freitas","raw_affiliation_strings":["Hospital da Senhora da Oliveira, Guimar\u00e3es, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital da Senhora da Oliveira, Guimar\u00e3es, Portugal;","institution_ids":["https://openalex.org/I4210098124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035782833","display_name":"Rui S. Magalh\u00e3es","orcid":"https://orcid.org/0000-0001-9860-0597","observed_orcids":["https://orcid.org/0000-0001-9860-0597"]},"institutions":[{"id":"https://openalex.org/I4210098124","display_name":"Hospital da Senhora da Oliveira Guimar\u00e3es","ror":"https://ror.org/00y0jw647","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210098124","https://openalex.org/I4405260793"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Rui Magalhaes","raw_affiliation_strings":["Hospital Senhora da Oliveira, Guimar\u00e3es, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Senhora da Oliveira, Guimar\u00e3es, Portugal;","institution_ids":["https://openalex.org/I4210098124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067361644","display_name":"Francisca Dias de Castro","orcid":"https://orcid.org/0000-0001-7633-9180","observed_orcids":["https://orcid.org/0000-0001-7633-9180"]},"institutions":[{"id":"https://openalex.org/I4210098124","display_name":"Hospital da Senhora da Oliveira Guimar\u00e3es","ror":"https://ror.org/00y0jw647","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210098124","https://openalex.org/I4405260793"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Francisca Dias de Castro","raw_affiliation_strings":["Gastroenterology Department, Hospital Senhora da Oliveira, Guimar\u00e3es, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastroenterology Department, Hospital Senhora da Oliveira, Guimar\u00e3es, Portugal","institution_ids":["https://openalex.org/I4210098124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043456532","display_name":"Maria Jo\u00e3o Moreira","orcid":"https://orcid.org/0000-0002-3442-3939","observed_orcids":["https://orcid.org/0000-0002-3442-3939"]},"institutions":[{"id":"https://openalex.org/I4210098124","display_name":"Hospital da Senhora da Oliveira Guimar\u00e3es","ror":"https://ror.org/00y0jw647","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210098124","https://openalex.org/I4405260793"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Maria Jo\u00e3o Moreira","raw_affiliation_strings":["Gastroenterology Department, Hospital Senhora da Oliveira, Guimar\u00e3es, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastroenterology Department, Hospital Senhora da Oliveira, Guimar\u00e3es, Portugal","institution_ids":["https://openalex.org/I4210098124"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053850016","display_name":"Jos\u00e9 B. Cotter","orcid":"https://orcid.org/0000-0002-2921-0648","observed_orcids":["https://orcid.org/0000-0002-2921-0648"]},"institutions":[{"id":"https://openalex.org/I4210098124","display_name":"Hospital da Senhora da Oliveira Guimar\u00e3es","ror":"https://ror.org/00y0jw647","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210098124","https://openalex.org/I4405260793"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Cotter","raw_affiliation_strings":["Gastroenterology Department, Hospital Senhora da Oliveira, Guimar\u00e3es, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastroenterology Department, Hospital Senhora da Oliveira, Guimar\u00e3es, Portugal","institution_ids":["https://openalex.org/I4210098124"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210098124"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"114","issue":"1","first_page":"S7","last_page":"S7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-infliximab-antibodies","display_name":"anti-infliximab antibodies","score":0.8360000252723694},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.8650000095367432},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.9369999766349792},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.7059999704360962},{"id":"https://openalex.org/keywords/loss-of-response","display_name":"loss of response","score":0.8740000128746033},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":0.8799999952316284},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.8659999966621399},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.5239999890327454},{"id":"https://openalex.org/keywords/premedication","display_name":"premedication","score":0.609000027179718},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.4309999942779541},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.5519999861717224},{"id":"https://openalex.org/keywords/sulfasalazine","display_name":"sulfasalazine","score":0.6510000228881836},{"id":"https://openalex.org/keywords/5-aminosalicylic-acid","display_name":"5-aminosalicylic acid","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.965566873550415},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9521499276161194},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.7979476451873779},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.7344140410423279},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.7282906770706177},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6925349831581116},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6359049677848816},{"id":"https://openalex.org/C2779280984","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn's disease","level":3,"score":0.5280053615570068},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5059277415275574},{"id":"https://openalex.org/C2778300832","wikidata":"https://www.wikidata.org/wiki/Q1589604","display_name":"Premedication","level":2,"score":0.4665370285511017},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.43503034114837646},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.42203861474990845},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38082778453826904},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2673661708831787}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/01.ajg.0000613072.37136.77","doi":"https://doi.org/10.14309/01.ajg.0000613072.37136.77","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0000613072.37136.77","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7165640515","https://openalex.org/W7125332914","https://openalex.org/W2106072130","https://openalex.org/W4401253159","https://openalex.org/W1085005885","https://openalex.org/W2969770936","https://openalex.org/W3012273290","https://openalex.org/W2018178851","https://openalex.org/W1992557034","https://openalex.org/W2288717210"],"abstract_inverted_index":{"BACKGROUND:":[0],"Anti-tumor":[1],"necrosis":[2],"factor":[3,288],"(TNF)-\u03b1":[4],"have":[5,226],"revolutionized":[6],"the":[7,80,96,127,141,173,285,290],"treatment":[8],"of":[9,19,33,40,76,84,117,121,129,133,143,158,166,193,262,299],"inflammatory":[10],"bowel":[11],"diseases":[12],"(IBD),":[13],"modifying":[14],"their":[15],"natural":[16],"history.":[17],"Loss":[18],"response":[20,300],"to":[21,42,176,203,225,296,301],"anti-TNFs":[22],"is":[23],"a":[24,73],"clinical":[25],"challenge":[26],"and":[27,67,71,98,107,137,172],"has":[28],"been":[29],"associated":[30,276],"with":[31,60,62,72,155,187,197,218,231,247,277],"formation":[32,45,178],"antibodies.":[34],"AIM:":[35],"To":[36],"identify":[37],"predictive":[38],"factors":[39],"antibodies":[41],"infliximab":[43,61,68,99,118],"(ATI)":[44],"in":[46],"IBD":[47,56],"patients.":[48],"METHODS:":[49],"Retrospective":[50],"single-center":[51],"study":[52],"including":[53],"all":[54],"consecutive":[55],"patients":[57,149,186,217,243],"being":[58],"treated":[59,196,246],"at":[63,89,101,126,140],"least":[64,90],"one":[65,91],"ATI":[66,85,168,188,205,228,278,291],"level":[69],"determination":[70,92],"minimum":[74],"follow-up":[75,97],"six":[77],"months":[78],"after":[79],"first":[81,144],"testing.":[82],"Presence":[83],"was":[86,93,169,179,214,274,284],"considered":[87],"if":[88],"positive":[94],"during":[95],"levels":[100,192],"this":[102],"testing":[103],"were":[104,150,200,222,244],"registered.":[105],"Clinical":[106],"demographic":[108],"data":[109],"obtained":[110],"included":[111],"disease":[112],"phenotype,":[113],"surgical":[114],"background,":[115],"duration":[116],"therapy,":[119],"use":[120,264],"premedication,":[122],"concomitant":[123,198,248],"immunomodulator":[124,263,282],"therapy":[125,283],"time":[128,142,175],"testing,":[130],"compliance,":[131],"occurrence":[132],"an":[134],"infusion":[135],"reaction":[136],"biochemical":[138],"assessment":[139],"induction":[145],"treatment.":[146],"RESULTS:":[147],"104":[148],"included,":[151],"56":[152],"females":[153],"(53.8%)":[154],"mean":[156,174],"age":[157],"38.2":[159],"\u00b1":[160,181],"13.1":[161],"years.":[162],"The":[163],"overall":[164],"prevalence":[165],"detectable":[167,227],"28.8%":[170],"(30)":[171],"its":[177,294],"32.8":[180],"24.3":[182],"months.":[183],"Most":[184],"(66.7%)":[185],"had":[189],"simultaneously":[190],"nontherapeutic":[191],"infliximab.":[194],"Patients":[195],"immunomodulators":[199,249],"less":[201,245],"likely":[202,224],"develop":[204],"(33%":[206],"versus":[207],"88%,":[208],"P":[209,238,253,266],"<":[210,267],"0.001).":[211,255],"Additionally,":[212],"it":[213],"found":[215],"that":[216],"Ulcerative":[219],"Colitis":[220],"(UC)":[221],"more":[223],"than":[229],"those":[230],"Crohn":[232],"Disease":[233],"(CD)":[234],"(44.4%":[235],"vs":[236,251],"23.4%,":[237],"=":[239,254],"0.04).":[240],"However,":[241],"UC":[242],"(48.1%":[250],"80.5%,":[252],"At":[256],"logistic":[257],"regression":[258],"analysis":[259],"only":[260,286],"lack":[261],"(":[265],"0.001;":[268],"OR":[269],"13.5,":[270],"CI":[271],"95%,":[272],"4.63\u201340.0)":[273],"independently":[275],"formation.":[279],"CONCLUSION(S):":[280],"Concomitant":[281],"protective":[287],"for":[289],"formation,":[292],"supporting":[293],"institution":[295],"prevent":[297],"loss":[298],"anti-TNFs.":[302]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2019-12-13T00:00:00"}